tradingkey.logo

Zoetis Inc

ZTS
View Detailed Chart

149.440USD

+2.480+1.69%
Close 04/11, 16:00(ET)Quotes delayed by 15 min
67.02BMarket Cap
26.96P/E TTM

Zoetis Inc

149.440

+2.480+1.69%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.69%

5 Days

-1.51%

1 Month

-6.64%

6 Months

-21.38%

Year to Date

-8.28%

1 Year

-0.36%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 20 analysts
BUY
Current Rating
203.369
Target Price
36.09%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
8
Average
Company name
Ratings
Analysts
Zoetis Inc
ZTS
20
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
32

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(3)
Buy(1)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-2.675
Sell
RSI(14)
39.142
Neutral
STOCH(KDJ)(9,3,3)
33.500
Neutral
ATR(14)
6.481
High Vlolatility
CCI(14)
-86.469
Neutral
Williams %R
63.326
Sell
TRIX(12,20)
-0.350
Sell
StochRSI(14)
84.854
Overbought
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
148.712
Buy
MA10
154.496
Sell
MA20
158.996
Sell
MA50
163.701
Sell
MA100
167.164
Sell
MA200
175.585
Sell

News

More news coming soon, stay tuned...

Company

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company codeZTS
CompanyZoetis Inc
CEOMs. Kristin C. Peck
Websitehttps://www.zoetis.com/
tradingkey.logo
tradingkey.logo
Intraday Data provided by Refinitiv and subject to terms of use. Historical and current end-of-day data provided by Refinitiv. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.